Bank of New York Mellon’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-186,823
| Closed | -$11.2M | – | 4245 |
|
|
2019
Q4 | $11.2M | Buy |
186,823
+8,274
| +5% | +$495K | ﹤0.01% | 1908 |
|
|
2019
Q3 | $5.02M | Buy |
178,549
+12,108
| +7% | +$340K | ﹤0.01% | 2277 |
|
|
2019
Q2 | $6.3M | Buy |
166,441
+7,508
| +5% | +$284K | ﹤0.01% | 2213 |
|
|
2019
Q1 | $6.2M | Buy |
158,933
+6,701
| +4% | +$261K | ﹤0.01% | 2227 |
|
|
2018
Q4 | $3.25M | Buy |
152,232
+24,462
| +19% | +$521K | ﹤0.01% | 2504 |
|
|
2018
Q3 | $5.06M | Buy |
127,770
+77
| +0.1% | +$3.05K | ﹤0.01% | 2404 |
|
|
2018
Q2 | $4.88M | Buy |
127,693
+31,048
| +32% | +$1.19M | ﹤0.01% | 2399 |
|
|
2018
Q1 | $2.9M | Buy |
96,645
+14,236
| +17% | +$428K | ﹤0.01% | 2618 |
|
|
2017
Q4 | $2.58M | Buy |
82,409
+27,687
| +51% | +$865K | ﹤0.01% | 2699 |
|
|
2017
Q3 | $1.53M | Buy |
54,722
+1,822
| +3% | +$51K | ﹤0.01% | 2986 |
|
|
2017
Q2 | $1.01M | Buy |
52,900
+34,057
| +181% | +$652K | ﹤0.01% | 3244 |
|
|
2017
Q1 | $321K | Buy |
18,843
+5,009
| +36% | +$85.3K | ﹤0.01% | 3727 |
|
|
2016
Q4 | $253K | Buy |
+13,834
| New | +$253K | ﹤0.01% | 3825 |
|